Strategic Development
Hyperfine and ISMRM Collaborate to Enhance Global Access to MR Education
Program seeks to increase neuroimaging clinical research and knowledge transfer between high-income and low- and medium-income countries
Products & Technologies
FDA Clears CorNeat EverPatch, World’s First Non-degradable, Synthetic Tissue Substitute for Ophthalmic Surgery
CorNeat Vision’s EverPatch Utilizes EverMatrix™, A Novel Material Technology Able to Integrate with Surrounding Tissue
Medical AI
Olympus to Establish Digital Excellence Centres around the World
DECs are to be located at current Olympus R&D sites in London, Hamburg, Boston and Tokyo, with the possibility of expanding to Silicon Valley and Tel Aviv at a later stage.
M&A
Avanos Medical to Sell its Respiratory Health Business to SunMed Group
The divestiture of the RH business represents a key component of Avanos’ ongoing three-year transformation process, and accelerates the Company’s efforts to focus its portfolio on markets where it is well positioned to succeed
Financing
Conformal Medical Closes $35M Series D Financing
Conformal Medical’s proprietary CLAAS technology features a foam-based architecture designed to conform to a broad range of LAA anatomies with only two sizes.
China
Siemens Healthineers Shanghai Diagnostic Manufacturing Facility Goes Into Production
the Diagnostic Facility will produce a wide range of diagnostic reagents for cardiac, thyroid, sex hormone, and oncology, as well as calibrators, diluents and quality control products for immuno-diagnostics, with an expected annual capacity of 600 million tests
Surgical
Olympus Launches Next Generation ESG-410 Electrosurgical Generator
The ESG-410 Electrosurgical Generator supports options and efficiencies in the treatment of NMIBC (non-muscle-invasive bladder cancer) and benign prostatic hyperplasia (BPH), or enlarged prostate, by providing an array of resection loops, band electrodes and vaporization buttons and needles
IVDs
GrapheneDx, General Graphene and Sapphiros Collaborate to Industrialize Graphene-Based Biosensors for Point-of-Care Diagnostics
announcing a strategic partnership to industrialize graphene-based biosensors for medical devices used to diagnose a variety of diseases at the point-of-care and in consumer setting
English (UK) 
简体中文 
Deutsch 
Français 
Español 
Português 
Italiano 
Nederlands